Scotiabank Upgrades Sarepta Therapeutics (BIT:1SRPT)

On June 6, 2025, Scotiabank upgraded Sarepta Therapeutics (BIT:1SRPT) to Sector Outperform from Sector Perform. Despite the upgrade, institutional ownership in Sarepta has decreased by 2.21% in the last three months to 111,356K shares, with 941 funds holding positions, a decrease of 6.09% from the previous quarter; however, the average portfolio weight dedicated to 1SRPT by these funds increased by 28.96% to 0.19%.

Analysis

Scotiabank's upgrade of Sarepta Therapeutics (SRPT) to 'Sector Outperform' on June 6, 2025, offers a positive market signal, yet it is set against a backdrop of shifting institutional sentiment. The number of funds holding SRPT positions decreased by 6.09% to 941 in the last quarter, and total institutional share ownership contracted by 2.21% to 111,356K shares. Conversely, the average portfolio weight of all funds dedicated to SRPT increased significantly by 28.96% to 0.19%, suggesting higher conviction or larger stakes among remaining or new institutional investors. This mixed institutional picture is underscored by specific fund activities: Capital International Investors increased its share count by 4.01% but reduced its portfolio allocation in SRPT by 42.76%, while Janus Henderson Group markedly decreased both its shareholding by 28.63% and its portfolio allocation by 83.96%. Even passive ETFs like IJH and VTSMX, despite marginal share increases of 0.45% and 1.01% respectively, saw their reported portfolio allocations to SRPT decrease by over 44%, reflecting potential relative underperformance or index reweighting. The overall sentiment for SRPT is consequently mixed, with a slight negative bias indicated by a -0.1 per-ticker sentiment score and a general sentiment score of -0.15.

Key Decisions for Investors

• Investors should consider Scotiabank's 'Sector Outperform' rating for Sarepta Therapeutics (SRPT) but critically assess the countervailing trend of reduced overall institutional ownership and fund participation.
• The notable 28.96% rise in average institutional portfolio allocation to SRPT warrants close observation to discern whether it signifies deepening conviction among a concentrated investor base or is an artifact of broader institutional outflows.
• Significant divestment and allocation reductions by active managers such as Janus Henderson, coupled with decreased relative weightings within major ETFs, suggest a cautious stance and necessitate further due diligence to reconcile these institutional behaviors with the analyst's upgraded outlook.